How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide-Reference-Cited by-同舟云学术

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide

Published:2019-11-20 Issue:21 Volume:134 Page:1802-1810
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

McCurdy Shannon R.¹²,Luznik Leo³⁴

Affiliation:

1. Abramson Cancer Center and

2. Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA; and

3. Department of Oncology and

4. Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD

Abstract

In this How I Treat article, the authors describe their clinical approach to this rapidly available transplantation platform and address some of the key clinical questions associated with its use.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/134/21/1802/1541365/bloodbld2019001323c.pdf

Reference73 articles.

1. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

2. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide;McCurdy;Blood,2015

3. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia;Ciurea;Blood,2015

4. Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?;Ringdén;Leukemia,2016

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis;Transplantation and Cellular Therapy;2024-08

2. Histocompatibility assessment in hematopoietic stem cell transplantation: recommendations from the Italian Society for Immunogenetics and Transplantation Biology (Associazione Italiana di Immunogenetica e Biologia dei Trapianti - AIBT);BLOOD TRANSFUS-ITALY;2024

3. Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC;Transplantation;2024-04-30

4. Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor;Blood Advances;2024-02-13

5. Sirolimus-induced Hypertriglyceridemia Leads to Acute Pancreatitis and Diabetic Ketoacidosis Post Stem Cell Transplant for Sickle Cell Disease;Journal of Pediatric Hematology/Oncology;2023-11-30